Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD’s not buying “The Antidote”

This article was originally published in The Tan Sheet

Executive Summary

Advertising for BiologicalMiracle.com's "The Antidote" will be referred to FDA for "possible law enforcement action," the National Advertising Division of the Council for Better Business Bureaus announces July 6. Product claims such as "kills all known deadly viruses and bacteria in the body" were brought to NAD's attention through its routine monitoring program. BiologicalMiracle "failed to submit a substantive response or provide any evidence to substantiate health claims" made for the product, the Council for Better Business Bureaus division states. The product was the target of an FDA Warning Letter in early 2004 (1"The Tan Sheet" Feb. 2, 2004, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098404

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel